Cargando…

Changes in Iron Metabolism Induced by Anti-Interleukin-6 Receptor Monoclonal Antibody are Associated with an Increased Risk of Infection

(1) Background: Treatment of patients with rheumatoid arthritis (RA) with an anti-IL-6 receptor (anti-IL-6R) monoclonal antibody (tocilizumab) has been found to influence iron metabolism. The objective of the present study was to ascertain whether changes in iron metabolism induced by anti-IL-6R bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ribeiro, Renata, Batista, Frederico, Seguro Paula, Filipe, Delgado Alves, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789697/ https://www.ncbi.nlm.nih.gov/pubmed/31261772 http://dx.doi.org/10.3390/ph12030100

Ejemplares similares

Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19
por: Douedi, Steven, et al.
Publicado: (2020)

Non-tumor necrosis factor-based biologic therapies for rheumatoid arthritis: present, future, and insights into pathogenesis
por: Paula, Filipe Seguro, et al.
Publicado: (2013)

Use of Anti-Interleukin-6 Receptor Monoclonal Antibody in Drug-Induced Acute Respiratory Distress Syndrome
por: Petrillo, Alessandra, et al.
Publicado: (2020)

SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
por: Jugler, Collin, et al.
Publicado: (2021)

Inhibition of murine B and T lymphopoiesis in vivo by an anti- interleukin 7 monoclonal antibody
Publicado: (1993)

A meta-analysis of anti-interleukin-13 monoclonal antibodies for uncontrolled asthma
por: Li, Hang, et al.
Publicado: (2019)

Mouse Anti‐human Interleukin‐6 Receptor Monoclonal Antibody Inhibits Proliferation of Fresh Human Myeloma Cells in vitro
por: Goto, Hideo, et al.
Publicado: (1994)

Establishment of Anti-Human ATRX Monoclonal Antibody AMab-6
por: Ogasawara, Satoshi, et al.
Publicado: (2016)

Monoclonal antibodies reactive with the mouse interleukin 5 receptor
Publicado: (1989)

Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice
Publicado: (1985)

Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
por: Chakraborty, Abhijit, et al.
Publicado: (2012)

Pharmacokinetics and pharmacodynamics of mepolizumab, an anti–interleukin 5 monoclonal antibody, in healthy Japanese male subjects
por: Tsukamoto, Naohiro, et al.
Publicado: (2015)

A Review of Three New Anti-interleukin-5 Monoclonal Antibody Therapies for Severe Asthma
por: Agumadu, Vivian C, et al.
Publicado: (2018)

Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children
por: Signa, Sara, et al.
Publicado: (2020)

Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
por: Koike, Ryuji, et al.
Publicado: (2009)

A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
por: Rossi, J-F, et al.
Publicado: (2010)

Lung transplantation for idiopathic multicentric Castleman disease: potential efficacy and tolerability of a humanized anti-interleukin-6 receptor monoclonal antibody
por: Tomioka, Yasuaki, et al.
Publicado: (2021)

Anti CD-6 Monoclonal Antibodies in the Management of Generalised Pustular Psoriasis
por: Kura, Mahendra M., et al.
Publicado: (2022)

Monoclonal antibodies specific for interleukin 3-sensitive murine cells
Publicado: (1986)

A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy
por: Goh, Angeline XH, et al.
Publicado: (2014)

Establishment of anti-mesothelioma monoclonal antibodies
por: Mizutani, Natsuko, et al.
Publicado: (2016)

A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma
por: Oh, Chad K, et al.
Publicado: (2013)

Laparoscopic transabdominal preperitoneal repair for inguinal hernia in a patient with an adult Still’s disease receiving anti-interleukin-6 receptor monoclonal antibody therapy
por: Mimatsu, Kenji, et al.
Publicado: (2022)

Interleukin-6(2)/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies
por: Rotundo, Salvatore, et al.
Publicado: (2023)

Modulating the interaction of graphenic substrates with human interleukin-6 and its monoclonal antibody: a study by Raman images
por: de la O-Cuevas, Emmanuel, et al.
Publicado: (2023)

Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism
por: Mühlbacher, Jakob, et al.
Publicado: (2021)

PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan
por: Yokota, S, et al.
Publicado: (2013)

A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease
por: van Rhee, Frits, et al.
Publicado: (2015)

In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A
Publicado: (1993)

A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus
por: McKie, Elizabeth A., et al.
Publicado: (2016)

Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma
por: Xu, Jiuhui, et al.
Publicado: (2023)

Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis
por: Lima, Cristiano Xavier, et al.
Publicado: (2015)

Commentary: Production and Characterization of Monoclonal Antibodies to Human Interleukin 2: Strategy and Tactics
por: Smith, Kendall A.
Publicado: (2015)

Treatment of Refractory Prurigo Nodularis with a Monoclonal Antibody Dupilumab with Surprising Clinical Response
por: Alves, Juliana P., et al.
Publicado: (2023)

Anti-interleukin-6 receptor antibody treatment ameliorates postoperative adhesion formation
por: Uyama, Naoki, et al.
Publicado: (2019)

Implications for White Matter Vulnerability to Anti-interleukin-6 Receptor Antibody Treatment
por: Kato, Daisuke
Publicado: (2020)

Linear IgA bullous dermatosis and elevated bullous interleukin‐6 levels: Responsive to treatment with Anti‐IL‐6 receptor monoclonals
por: Jordan, Stanley C., et al.
Publicado: (2023)

Anti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects
Publicado: (1988)

Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism
Publicado: (1990)

Eosinophilic Granulomatosis with Polyangiitis Presenting with Central Retinal Artery Occlusion During Treatment with Anti-interleukin-5 Receptor Monoclonal Antibody
por: Nishiyama, Hirono, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tfnntrboe217lbdp6l820h6u0f